Characteristics

Frequencies

Therapeutic Success CV < 2, 30 log₁₀

104 (75.4%)

Therapeutic Failure CV > 2, 30 log₁₀

34 (24.6%)

Age Interval

<2, 30 log₁₀

>2, 30 log₁₀

18 - 25

18 (17.3%)

12 (35.3%)

26 - 35

31 (29.8%)

8 (23.5%)

36 - 45

31 (29.8%)

8 (23.5%)

46 - 55

19 (18.3%)

4 (11.8%)

56 - 65

5 (4.8%)

2 (5.9%)

Total

104

34

Type of Virological Failure (RNA copies/ml)

Minimal Failure (2, 30 < CV < 3, 70 log₁₀)

8 (23.5%)

Moderate Failure (3, 70 < CV < 4, 48 log₁₀)

23 (67.7%)

Severe Failure (CV > 4, 48 log₁₀)

3 (8.8%)